Postbronchoscopy expectoration of tumour tissue in lung cancer
Dixit, R.; Joshi, N.; Nuwal, P.; Purohit, S.D.; Gupta, R.C.; Gupta, N.
Indian Journal of Chest Diseases and Allied Sciences 41(2): 105-109
1999
ISSN/ISBN: 0377-9343 PMID: 10437323 Document Number: 501412
A case of undifferentiated giant cell type bronchogenic carcinoma in an old man is reported. Following bronchoscopy, the patient expectorated tumour mass tissue in his sputum and was relieved of breathlessness to a great extent.
Document emailed within 1 workday
Related Documents
Solopov, V.N.; Lunichkina, I.V. 1990: Expectoration disorders in patients with chronic obstructive lung diseases Klinicheskaia Meditsina 68(5): 60-65Srabović, N.; Mujagić, Z.; Mujanović-Mustedanagić, J.; Muminović, Z.; Cickusić, E. 2011: Interleukin 18 expression in the primary breast cancer tumour tissue Medicinski Glasnik: Official Publication of the Medical Association of Zenica-Doboj Canton Bosnia and Herzegovina 8(1): 109-115
Schmidt, L.H.; Biesterfeld, S.; Kümmel, A.; Faldum, A.; Sebastian, M.; Taube, C.; Buhll, R.; Wiewrodt, R. 2009: Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue Anticancer Research 29(1): 201-209
Zhang, X.; Fan, X.-y.; Zhang, Y.-s. 2010: P16 and Rb protein in lung tissue of patients with coal workers' pneumoconiosis and lung cancer Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 28(5): 355-357
Ruiz Moral, R.; Torre-Cisneros, J.; Cosano, A.; López Pujol, J.; Muñoz, R.; Pérez Jiménez, F. 1989: Usefulness of determining 2 cell membrane enzymes in bronchial aspirate and lung tissue in patients with cancer of the lung Revista Clinica Espanola 185(6): 291-294
Pelosi, E.; Billè, A.; Skanjeti, A.; Errico, L.; Arena, V.; Ardissone, F.; Borasio, P.; Mancini, M. 2011: Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(1): 72-80
Pelosi, E.; Billè, A.; Skanjeti, A.; Errico, L.; Arena, V.; Ardissone, F.; Borasio, P.; Mancini, M. 2011: Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(1): 72-80
Chantapet, P.; Riantawan, P.; Lebnak, P.; Getngern, P. 2000: Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer Journal of the Medical Association of Thailand 83(4): 383-391
Gemma, H.; Sato, A. 1989: Effect of glucocorticoid on lung tissue and bronchus-associated lymphoid tissue of experimental granulomatous lung Kekkaku: 64(6): 387-399
Yusa, T.; Tamiya, N.; Yamaguchi, Y.; Takeda, T.; Ogawa, T.; Kimura, H.; Fujimura, S. 1994: A study of thymidine kinase activity in lung cancer tissue Nihon Kyobu Shikkan Gakkai Zasshi 32(3): 211-215
Kato, H.; Inoue, S.; Takahashi, K.; Yamanaka, A.; Okada, Y. 1987: UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1866-1870
Kaban, A.P.; Golovinskiĭ, B.G.; Lisetskiĭ, V.A.; Ivanova, N.O. 1983: Changes in gas exchange and tissue circulation in patients with surgically treated lung cancer Grudnaia Khirurgiia 1983(5): 34-36
Rogalla, P.; Drechsler, K.; Schröder-Babo, W.; Eberhardt, K.; Bullerdiek, J. 1998: HMGIC expression patterns in non-small lung cancer and surrounding tissue Anticancer Research 18(5a): 3327-3330
Quillien, V.; Ramee, M.P.; Bansard, J.Y.; Meritte, H.; Briens, E.; Logeais, Y.; Langanay, T.; Corbineau, H.; Dazord, L. 1995: Serum and tissue distribution of a fragment of cytokeratin 19 (cyfra 21-1) in lung cancer patients Anticancer Research 15(6b): 2857-2863
Bershteĭn, L.M.; Barchuk, A.S.; Lemekhov, V.G.; Seleznev, I.K.; Semiglazov, V.F. 1983: Morphometric and biochemical peculiarities of fatty tissue in patients with cancer of the breast and lung Voprosy Onkologii 29(4): 45-51
Lai, C-Yu.; Chang, W-Shin.; Hsieh, Y-Hsien.; Hsu, C-Mu.; Tsai, C-Wen.; Chen, A-Chyi.; Wang, C-Hsing.; Bau, D-Tian. 2016: Association of Tissue Inhibitor of Metalloproteinase-1 Genotypes with Lung Cancer Risk in Taiwan Anticancer Research 36(1): 155-160
Fu, D.; Liu, B.; Wang, H. 1997: Detection of p53 gene mutation in paraffin-embedded asbestos-related lung cancer tissue Zhonghua Yu Fang Yi Xue Za Zhi 31(4): 206-208
Wang, X-Yun.; Yao, Z.; Li, Y.; Liu, T.; Zheng, H-Yan.; Zhu, C-Zhong.; Sun, C-Yun.; Wang, A-Xiang.; Zhao, M.; Wu, X-Ye. 2005: Expression and significance of Survivin mRNA in lung cancer tissue microarray detected by FISH Chinese Medical Sciences Journal 20(3): 214-216
Yang, M.; Ye, C.; Yao, S.; Zhang, J.; Chen, J.; Liu, L. 1999: Preliminary studies on tin miners' lung cancer tissue related genes by differential display mRNA Chinese Medical Journal 112(6): 529-533
Browne, W.L.; Wilson, W.R.; Baguley, B.C.; Ching, L.M. 1998: Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid Anticancer Research 18(6a): 4409-4413